Biopsomic is developing a new liquid biopsy for cancer prognosis.
From a simple blood draw, our non-invasive test probes the actual disease state and evaluates the risk of developing metastatic disease based on the analysis of nanovesicles called exosomes.
These new insights allow oncologists to make proper well-informed clinical decisions and ensure optimal outcomes for patients.
We are currently looking for new team members.
Company Details
Biopsomic Questions
Biopsomic's LinkedIn profile is https://ch.linkedin.com/company/biopsomic
Biopsomic has
2 employees.
View email and phone details for 2
employees at Biopsomic.
Biopsomic's industry is
Biotechnology
Biopsomic's top competitors are
Iucn Business And Nature,
Find,
Abionic,
Evis Bioscience Ag,
Connected Diagnostics,
Cistec Ag,
Biorender,
Anatomage Inc.,
Rapidai,
Lelaps.
Biopsomic's categories are Biotechnology
Biopsomic's founding year is 2019
